Absci (ABSI) EBT (2020 - 2026)
Absci's (ABSI) quarterly EBT came in at -$29.6 million in Q1 2026, down 12.26% year-on-year from -$33.7 million in Q1 2025, and little changed quarter-over-quarter from -$29.7 million in Q4 2025.
Absci (ABSI) EBT (2020 - 2026) Analysis & Trends
Absci has disclosed EBT across 7 years of filings, most recently posting -$29.6 million for Q1 2026.
- EBT for Q1 2026 came in at -$29.6 million, down 12.26% year-over-year; the trailing twelve-month figure through Mar 2026 was -$118.3 million (down 10.17% YoY), and the FY2025 annual result was -$115.1 million, down 11.72% from the prior year.
- EBT came in at -$29.6 million for Q1 2026 at Absci, roughly flat from -$29.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$20.0 million in Q4 2022 to a low of -$41.7 million in Q2 2023.
- The 5-year median for EBT is -$27.6 million (2022), against an average of -$27.3 million.
- Across the five-year window, EBT sank 152.41% in 2022 and jumped 40.59% in 2024, its largest moves.
- Absci's EBT stood at -$20.0 million in 2022, then decreased by 17.66% to -$23.5 million in 2023, then declined by 23.26% to -$29.0 million in 2024, then retreated by 2.63% to -$29.7 million in 2025, then climbed by 0.48% to -$29.6 million in 2026.
- The last three EBT figures came in at -$29.6 million (Q1 2026), -$29.7 million (Q4 2025), and -$28.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -29.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.58 Mn |
| Dec 31, 2025 | -29.72 Mn |
| Sep 30, 2025 | -28.60 Mn |
| Jun 30, 2025 | -30.44 Mn |
| Mar 31, 2025 | -26.35 Mn |
| Dec 31, 2024 | -28.96 Mn |
| Sep 30, 2024 | -27.36 Mn |
| Jun 30, 2024 | -24.75 Mn |
| Mar 31, 2024 | -21.96 Mn |
| Dec 31, 2023 | -23.50 Mn |
| Sep 30, 2023 | -21.96 Mn |
| Jun 30, 2023 | -41.66 Mn |
| Mar 31, 2023 | -23.35 Mn |
| Dec 31, 2022 | -19.97 Mn |
| Sep 30, 2022 | -27.57 Mn |
| Jun 30, 2022 | -28.95 Mn |
| Mar 31, 2022 | -28.87 Mn |
| Dec 31, 2021 | -26.27 Mn |
| Sep 30, 2021 | -25.34 Mn |
| Jun 30, 2021 | -46.82 Mn |